Identifying, understanding, and curing disease is a lifelong endeavor for any medical practitioner. Equally as important is to be cognizant of the impact a disease has on the individual suffering from it, as well as on their family. Ovarian cancer is the leading cause of death from gynecologic malignancies. Symptoms are vague, and the disease is generally at an advanced stage at diagnosis. Efforts have been made to develop methods to identify ovarian cancer at earlier stages, thus improving overall mortality. Transvaginal ultrasound (TVUS), with and without laboratory tests, can be used to screen for ovarian cancer. For over thirty years, the University of Kentucky Markey Cancer Center Ovarian Cancer Screening Program has been studying the ...
Epithelial ovarian cancer (EOC) is the predominant type of ovarian cancer (OC). The 5-year survival ...
Ovarian cancer is the fifth most common cause of death from cancer in women after lung, breast, colo...
Ovarian cancer is the foremost cause of gynecological cancer death in the developed world, as it is ...
Transvaginal ultrasonography (TVS) is an integral part of all major ovarian cancer screening trials....
Presented here are scientific reports which add considerable information to the area of early stage ...
Ovarian cancer is predominantly a disease of postmenopausal women which presents at a late stage and...
In North America, ovarian cancer is the second mostcommon gynecologic malignant disease and is the l...
Abstract. Despite advances in therapy, ovarian cancer remains the most deadly of the gynecological c...
Despite advances in therapy, ovarian cancer remains the most deadly of the gynecological cancers. Le...
Ovarian cancer is associated with an overall mortality of 75%, but can be cured in up to 90 % of cas...
Women with a family history of ovarian cancer represent a high-risk group for the development of epi...
Vol. 4 No.2 co nt in ui ng educationfor n ursing I n T h i s I s s u e O varian cancer has been call...
Ovarian cancer screening using pelvic examination, CA-125 serum tumor marker, transvaginal ultrasoun...
Ovarian cancer is in frequency the third cancer of female genital tract, after those of uterus and c...
Purpose To assess the effectiveness of annual ovarian cancer screening (transvaginal ultrasound and ...
Epithelial ovarian cancer (EOC) is the predominant type of ovarian cancer (OC). The 5-year survival ...
Ovarian cancer is the fifth most common cause of death from cancer in women after lung, breast, colo...
Ovarian cancer is the foremost cause of gynecological cancer death in the developed world, as it is ...
Transvaginal ultrasonography (TVS) is an integral part of all major ovarian cancer screening trials....
Presented here are scientific reports which add considerable information to the area of early stage ...
Ovarian cancer is predominantly a disease of postmenopausal women which presents at a late stage and...
In North America, ovarian cancer is the second mostcommon gynecologic malignant disease and is the l...
Abstract. Despite advances in therapy, ovarian cancer remains the most deadly of the gynecological c...
Despite advances in therapy, ovarian cancer remains the most deadly of the gynecological cancers. Le...
Ovarian cancer is associated with an overall mortality of 75%, but can be cured in up to 90 % of cas...
Women with a family history of ovarian cancer represent a high-risk group for the development of epi...
Vol. 4 No.2 co nt in ui ng educationfor n ursing I n T h i s I s s u e O varian cancer has been call...
Ovarian cancer screening using pelvic examination, CA-125 serum tumor marker, transvaginal ultrasoun...
Ovarian cancer is in frequency the third cancer of female genital tract, after those of uterus and c...
Purpose To assess the effectiveness of annual ovarian cancer screening (transvaginal ultrasound and ...
Epithelial ovarian cancer (EOC) is the predominant type of ovarian cancer (OC). The 5-year survival ...
Ovarian cancer is the fifth most common cause of death from cancer in women after lung, breast, colo...
Ovarian cancer is the foremost cause of gynecological cancer death in the developed world, as it is ...